M.R. Girvigian

894 total citations
34 papers, 523 citations indexed

About

M.R. Girvigian is a scholar working on Epidemiology, Neurology and Genetics. According to data from OpenAlex, M.R. Girvigian has authored 34 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Neurology and 11 papers in Genetics. Recurrent topics in M.R. Girvigian's work include Meningioma and schwannoma management (20 papers), Glioma Diagnosis and Treatment (11 papers) and Vascular Malformations Diagnosis and Treatment (10 papers). M.R. Girvigian is often cited by papers focused on Meningioma and schwannoma management (20 papers), Glioma Diagnosis and Treatment (11 papers) and Vascular Malformations Diagnosis and Treatment (10 papers). M.R. Girvigian collaborates with scholars based in United States and Japan. M.R. Girvigian's co-authors include J. Rahimian, Michael J. Miller, Joseph C.T. Chen, Joseph C. Chen, Ajay A. Rao, Michael Tomé, Nicholas Ling, Akira Nakatani, Michael M. Miller and Gregory F. Erickson and has published in prestigious journals such as Journal of neurosurgery, International Journal of Radiation Oncology*Biology*Physics and Neurosurgery.

In The Last Decade

M.R. Girvigian

32 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.R. Girvigian United States 15 283 256 140 139 83 34 523
Marcello Marchetti Italy 15 272 1.0× 239 0.9× 94 0.7× 176 1.3× 149 1.8× 34 512
Susan F. Dunbar United States 8 136 0.5× 199 0.8× 43 0.3× 190 1.4× 166 2.0× 10 572
Mitsunobu Ide Japan 17 410 1.4× 554 2.2× 32 0.2× 176 1.3× 163 2.0× 36 808
Elias Dagnew United States 10 265 0.9× 267 1.0× 38 0.3× 147 1.1× 89 1.1× 12 441
Paul L. OʼBoynick United States 11 178 0.6× 197 0.8× 104 0.7× 299 2.2× 80 1.0× 15 581
L. Casentini Italy 14 414 1.5× 671 2.6× 36 0.3× 146 1.1× 161 1.9× 25 869
Hamid Borghei-Razavi United States 12 187 0.7× 159 0.6× 44 0.3× 182 1.3× 112 1.3× 56 438
Shunsuke Kawamoto Japan 19 497 1.8× 1.1k 4.3× 90 0.6× 273 2.0× 142 1.7× 74 1.4k
Minoru Jimbo Japan 16 409 1.4× 688 2.7× 44 0.3× 161 1.2× 85 1.0× 40 857
Costantino De Renzis Italy 13 174 0.6× 119 0.5× 38 0.3× 115 0.8× 136 1.6× 26 489

Countries citing papers authored by M.R. Girvigian

Since Specialization
Citations

This map shows the geographic impact of M.R. Girvigian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Girvigian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Girvigian more than expected).

Fields of papers citing papers by M.R. Girvigian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Girvigian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Girvigian. The network helps show where M.R. Girvigian may publish in the future.

Co-authorship network of co-authors of M.R. Girvigian

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Girvigian. A scholar is included among the top collaborators of M.R. Girvigian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Girvigian. M.R. Girvigian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rahimian, J., et al.. (2023). Impact of Concurrent Targeted Therapy and Immunotherapy on the Incidence of Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 117(2). e86–e86.
3.
Rahimian, J., et al.. (2023). Adaptive Dose-Staged Stereotactic Ablative Body Radiotherapy for Treatment of Large Central NSCLC Lung Tumors: A Dosimetric Simulation Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e709–e709. 2 indexed citations
4.
Miller, Michael J., et al.. (2020). Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery. Advances in Radiation Oncology. 5(5). 850–855. 5 indexed citations
5.
Miller, Michael J., et al.. (2019). Long-Term Outcomes for Arteriovenous Malformations treated with LINAC-based Stereotactic Radiosurgery in the Pediatric Population. International Journal of Radiation Oncology*Biology*Physics. 105(1). E631–E631. 1 indexed citations
6.
Zhi, M, M.R. Girvigian, Michael J. Miller, et al.. (2018). Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy. World Neurosurgery. 122. e1153–e1161. 37 indexed citations
7.
Valicenti, Richard K., Stephanie L. Pugh, Edouard J. Trabulsi, et al.. (2017). First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 100(3). 695–701. 4 indexed citations
9.
Girvigian, M.R., et al.. (2012). A Comparative Study of Stereotactic Radiosurgery, Hypofractionated, and Fractionated Stereotactic Radiotherapy in the Treatment of Skull Base Meningioma. American Journal of Clinical Oncology. 37(3). 255–260. 32 indexed citations
10.
Chen, Joseph C.T., et al.. (2010). Frameless Image-Guided Radiosurgery for Initial Treatment of Typical Trigeminal Neuralgia. World Neurosurgery. 74(4-5). 538–543. 28 indexed citations
11.
Rahimian, J., et al.. (2010). Frameless Stereotactic Radiosurgery of Arteriovenous Malformations using High Resolution 3D Rotational Angiograms, and Novalis ExacTrac Systems. International Journal of Radiation Oncology*Biology*Physics. 78(3). S774–S774. 1 indexed citations
12.
Chen, Joseph C.T., et al.. (2009). Control of brain metastases using frameless image-guided radiosurgery. Neurosurgical FOCUS. 27(6). E6–E6. 15 indexed citations
13.
Chen, Joseph C.T., et al.. (2008). PROGNOSTIC FACTORS FOR RADIOSURGERY TREATMENT OF TRIGEMINAL NEURALGIA. Neurosurgery. 62(5). A53–A61. 23 indexed citations
14.
Chen, Joseph C.T., J. Rahimian, M.R. Girvigian, & Michael J. Miller. (2007). Contemporary methods of radiosurgery treatment with the Novalis linear accelerator system. Neurosurgical FOCUS. 23(6). E3–E3. 3 indexed citations
15.
Girvigian, M.R., et al.. (2005). Validation of a Radiosurgery-Based Grading System for Arteriovenous Malformations. International Journal of Radiation Oncology*Biology*Physics. 63. S432–S432. 6 indexed citations
16.
Girvigian, M.R., et al.. (2004). Squamous Cell Carcinoma Arising in a Second Branchial Cleft Cyst. American Journal of Clinical Oncology. 27(1). 96–100. 22 indexed citations
17.
Girvigian, M.R., et al.. (2003). Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: A prospective randomized trial. Brachytherapy. 2(4). 229–239. 2 indexed citations
18.
Kleisli, Thomas, M.R. Girvigian, Oscar E. Streeter, et al.. (2003). Use of High-Dose-Rate Brachytherapy in the Management of Locally Recurrent Rectal Cancer. Diseases of the Colon & Rectum. 46(7). 895–899. 16 indexed citations
19.
Erickson, Gregory F., et al.. (1995). Tissue specific and cyclic expression of insulin-like growth factor binding proteins-1,-2,-3,-4,-5,-6 in the rat oviduct. Endocrine. 3(9). 667–676. 1 indexed citations
20.
Girvigian, M.R., Akira Nakatani, Nicholas Ling, Shunichi Shimasaki, & Gregory F. Erickson. (1994). Insulin-Like Growth Factor Binding Proteins Show Distinct Patterns of Expression in the Rat Uterus1. Biology of Reproduction. 51(2). 296–302. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026